肿瘤消融市场规模、份额、成长分析（按技术、疗法、应用、最终用户、地区）- 2025 年至 2032 年产业预测

预计肿瘤消融市场规模在 2023 年将达到 19 亿美元，并从 2024 年的 21.7 亿美元增长到 2032 年的 62.8 亿美元，预测期内（2025-2032 年）的复合年增长率为 14.2%。

全球癌症发生率的上升以及对微创治疗方法的日益偏好预计将在未来几年推动对肿瘤消融技术的需求。消融技术的创新有望为供应商创造新的商机。门诊肿瘤消融手术的日益普及和联合治疗的日益普及可能会推动产品销售的大幅成长。此外，对新型癌症治疗方法的需求不断增长以及对肿瘤学研究的投资活性化可能会进一步扩大商业潜力。新兴市场蕴藏着巨大的商机，尤其是癌症发生率不断上升的中低收入国家。然而，设备高成本、传统治疗方法的竞争以及新兴市场认知度低等挑战可能会阻碍市场长期发展。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

肿瘤消融市场规模（依技术及复合年增长率） (2025-2032)

• 市场概览
• 射频
• 微波
• 不可逆电穿孔
• 冷冻疗法

肿瘤消融治疗市场规模（按治疗类型和复合年增长率） (2025-2032)

• 市场概览
• 手术消融
• 经经皮消融
• 腹腔镜消融术

肿瘤消融市场规模（依应用划分）及复合年增长率（2025-2032）

• 市场概览
• 肺癌
• 肾癌
• 肝癌

肿瘤消融治疗市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院和诊所
• 专业中心

肿瘤消融治疗市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Medtronic plc（Ireland）
• Boston Scientific Corporation（USA）
• Johnson & Johnson（USA）
• Abbott Laboratories（USA）
• Varian Medical Systems, Inc.（USA）
• Olympus Corporation（Japan）
• AngioDynamics, Inc.（USA）
• Terumo Corporation（Japan）
• Siemens Healthineers AG（Germany）
• Merit Medical Systems, Inc.（USA）
• EDAP TMS SA（France）
• Stryker Corporation（USA）
• Hologic, Inc.（USA）
• IceCure Medical Ltd.（Israel）
• Galil Medical, Inc.（USA）
• ConMed Corporation（USA）
• Neuwave Medical, Inc.（USA）
• SonaCare Medical LLC.（USA）
• Mermaid Medical A/S（Denmark）

结论和建议

Tumor Ablation Market size was valued at USD 1.9 billion in 2023 and is poised to grow from USD 2.17 billion in 2024 to USD 6.28 billion by 2032, growing at a CAGR of 14.2% during the forecast period (2025-2032).

The global rise in cancer incidence, coupled with a growing preference for minimally invasive treatment approaches, is poised to drive demand for tumor ablation techniques in the coming years. Innovations in ablation technologies are expected to unlock fresh opportunities for providers within this landscape. The increasing adoption of tumor ablation procedures in outpatient settings, along with the rising popularity of combination therapies, is likely to enhance product sales significantly. Additionally, the surging need for novel cancer treatments and bolstered investments in oncology research will further expand business potential. Emerging markets, particularly low to middle-income countries facing escalating cancer rates, present considerable opportunities. However, challenges such as the high costs of equipment, competition from conventional therapies, and limited awareness in developing regions may hinder long-term market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Tumor Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Tumor Ablation Market Segments Analysis

Global Tumor Ablation Market is segmented by Technology, Treatment, Application, End User and region. Based on Technology, the market is segmented into Radiofrequency, Microwave, Irreversible Electroporation and Cryoablation. Based on Treatment, the market is segmented into Surgical Ablation, Percutaneous Ablation and Laparoscopic Ablation. Based on Application, the market is segmented into Lung Cancer, Kidney Cancer and Liver Cancer. Based on End User, the market is segmented into Hospitals and Clinics and Specialty Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Tumor Ablation Market

The rising global prevalence of cancer is accelerating the demand for tumor ablation therapies, which are expected to play a crucial role in cancer management in the coming years. Tumor ablation offers a minimally invasive treatment option for various cancers, including those affecting the liver, lungs, and kidneys, making it particularly appealing for patients who are not suitable candidates for traditional surgical procedures. As the number of cancer cases continues to grow worldwide, the need for innovative and effective treatment solutions like tumor ablation is becoming increasingly important, highlighting its significance in the evolving landscape of oncological care.

Restraints in the Tumor Ablation Market

The tumor ablation market faces significant restraints primarily due to the high costs associated with the advanced technologies used in tumor ablation equipment. This steep pricing not only escalates the overall cost of treatment but also limits access for healthcare facilities with constrained budgets. As a result, the financial burden posed by such expensive equipment is a major factor hindering market growth and accessibility, presenting a notable challenge for providers looking to offer these innovative treatment options. Consequently, the high costs of tumor ablation products remain a critical constraint impacting the market outlook and expansion prospects.

Market Trends of the Tumor Ablation Market

The Tumor Ablation market is witnessing a significant trend towards the integration of advanced imaging guidance technologies, enhancing procedural accuracy and patient outcomes. Companies are increasingly adopting real-time imaging modalities such as MRI, CT, and ultrasound to improve the precision of ablation techniques, ultimately reducing complications and elevating success rates. This focus on imaging innovations not only streamlines the ablation procedures but also positions firms favorably in a competitive landscape where efficacy and safety are paramount. As healthcare providers seek to optimize treatment protocols, the demand for such technological advancements is expected to drive market growth in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Tumor Ablation Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Radiofrequency
• Microwave
• Irreversible Electroporation
• Cryoablation

Global Tumor Ablation Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Surgical Ablation
• Percutaneous Ablation
• Laparoscopic Ablation

Global Tumor Ablation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Lung Cancer
• Kidney Cancer
• Liver Cancer

Global Tumor Ablation Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Specialty Centers

Global Tumor Ablation Market Size & CAGR (2025-2032)

• North America (Technology, Treatment, Application, End User)
  • US
  • Canada
• Europe (Technology, Treatment, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Treatment, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Treatment, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Treatment, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EDAP TMS S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IceCure Medical Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galil Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ConMed Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuwave Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SonaCare Medical LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mermaid Medical A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations